Abattis completes acquisition of Canadian fertiliser and nutrient company

Abattis Bioceuticals Corp has successfully completed its acquisition  of NutriVida in the United States and Europe, and Pi Nutrients in Canada, a privately held British Columbia fertilizer and nutrient company.

Abattis is a fully integrated medicinal cannabis company. Abattis Bioceuticals’ portfolio consists of Pro Natura BV, Pi Nutrients, NutriVida USA, Gabriola Green Farms, Select Strains, Green Tree Therapeutics, Vergence Naturals and Comfort.

Pi Nutrients’ management team specialises in the research, innovation, manufacturing and selling of fertilizers and soil amendments to the hydroponic and garden centre industries. They have been active in the innovation and technological advancement of the hydroponic sector since 1978, specifically in regards to the cultivation and production of cannabis. 

“Abattis continues to hit significant milestones as we remain focused on revenue growth in the company,” stated President and CEO of Abattis, Robert Abenante. “We are very excited to have completed the acquisition of Pi Nutrients, as we believe it will significantly contribute to the company’s revenue generation alongside our other recent acquisition, Pro Natura BV” added Mr. Abenante.

In connection with the closing, the board of directors of the company will be increased to include a nominee of Pi Nutrients. It is expected that Kelly Zastowny will be appointed as Pi Nutrients’ nominee.

Mr. Zastowny has over 35 years of experience within the plant nutrient industry, and was a key figure in the research and development of modern hydroponic technology in North America, Engand, New Zealand and Eastern Europe. Mr. Zastowny has served as the past President of NutriLife from 1990 until the end of 2017, and is the current president of Pi Nutrients.

For more information:

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.